7.2 Synaptic Transmission & Key Neurotransmitters

7.2 Synaptic Transmission & Key Neurotransmitters

Individual neurons do not operate as isolated electrical wires; instead, they communicate through complex networks connected by specialized junctions called synapses. At these cellular intersections, electrical signals arriving from an upstream neuron are translated, modulated, and integrated before being relayed to a downstream target. Understanding the biochemical steps of synaptic transmission, the ionic distinctions between excitatory and inhibitory potentials, and the specific physiological roles of major neurotransmitters is foundational to mastering nervous system pharmacology and pathology.

---

Synapse Structure: Electrical vs. Chemical Synapses

A synapse is a functional junction that mediates information transfer from one neuron to another, or from a neuron to an effector cell (such as a skeletal muscle fiber at a neuromuscular junction or a glandular epithelial cell). The neuron conducting impulses toward the synapse is designated the presynaptic neuron, while the neuron or effector transmitting electrical signals away from the synapse is the postsynaptic neuron or postsynaptic cell.

+-------------------------------------------------------------------------+
|                   ELECTRICAL VS. CHEMICAL SYNAPSE                       |
|                                                                         |
|   ELECTRICAL SYNAPSE:                       CHEMICAL SYNAPSE:           |
|   Direct Cytoplasmic Bridge                 Fluid-Filled Synaptic Cleft |
|                                                                         |
|   Presynaptic   Connexon                    Presynaptic   Synaptic      |
|   Neuron        Channels                    Axon Terminal Vesicles      |
|   +---------+   (Gap Junctions)             +---------+   (with NT)     |
|   |         |===                            |  (Ca2+) |    [ooo]        |
|   |         |===  Direct Ion Flow           |    v    |     ---         |
|   |         |===  (Instantaneous)           |   ---   |                 |
|   +---------+                               +----+----+                 |
|   Postsynaptic                              =================== Cleft   |
|   Neuron                                    +----+----+ (20-50 nm)      |
|   +---------+                               | [Receptor Channels]       |
|   |         |                               +---------+                 |
|   |         |                               Postsynaptic                |
|   +---------+                               Dendrite or Soma            |
+-------------------------------------------------------------------------+

1. Electrical Synapses

In an electrical synapse, the plasma membranes of the presynaptic and postsynaptic neurons lie in direct physical apposition, connected by specialized protein complexes called gap junctions. Each gap junction consists of paired tubular channel proteins called connexons. Ions flow directly and passively through these aqueous channel pores from the cytoplasm of one neuron into the next.

• Characteristics: Transmission is virtually instantaneous, introduces no synaptic delay, and is frequently bidirectional.
• Physiological Role: Electrical synapses synchronize the electrical activity of entire cell populations. In the adult nervous system, they are found in specialized brainstem nuclei controlling rhythmic breathing, eye tracking circuits, and the embryonic nervous system. In non-neuronal tissues, gap junctions are prominent in cardiac muscle intercalated discs and visceral smooth muscle sheets.

2. Chemical Synapses

In contrast, chemical synapses represent the vast majority of synapses in the human nervous system. The presynaptic and postsynaptic membranes never physically touch; instead, they are separated by a fluid-filled extracellular space measuring approximately 20 to 50 nanometers (nm) wide, designated the synaptic cleft.

• Mechanism: Electrical nerve impulses cannot physically jump across the fluid-filled cleft. Instead, the electrical action potential is converted at the presynaptic terminal into a chemical messenger molecule (neurotransmitter). The neurotransmitter diffuses across the cleft and binds to specific receptor proteins on the postsynaptic membrane, regenerating an electrical signal.
• Characteristics: Transmission across chemical synapses is strictly unidirectional (from presynaptic terminal to postsynaptic receptor) and introduces a characteristic synaptic delay of approximately 0.3 to 0.5 milliseconds (ms). Synaptic delay represents the rate-limiting step in neural conduction, explaining why complex multisynaptic reflex arcs take longer to execute than monosynaptic circuits.

---

The Sequential Steps of Chemical Synaptic Transmission

Chemical synaptic transmission proceeds through an orderly cascade of electrophysiological and biochemical events:

+-------------------------------------------------------------------------+
|               CASCADE OF CHEMICAL SYNAPTIC TRANSMISSION                 |
|                                                                         |
|   Step 1: Action Potential Arrives at Presynaptic Axon Terminal         |
|                              |
|                              v
|   Step 2: Voltage-Gated Ca2+ Channels Open -> Rapid Ca2+ Influx         |
|                              |
|                              v
|   Step 3: Ca2+ Triggers Synaptic Vesicle Exocytosis of Neurotransmitter |
|                              |
|                              v
|   Step 4: Neurotransmitter Diffuses Across Synaptic Cleft (20-50 nm)    |
|                              |
|                              v
|   Step 5: Neurotransmitter Binds Specific Postsynaptic Ligand Receptors |
|                              |
|                              v
|   Step 6: Chemically-Gated Ion Channels Open -> EPSP (Na+) or IPSP (Cl- / K+) 
|                              |
|                              v
|   Step 7: Termination of Signal (Enzymatic Cleavage, Reuptake, Diffusion) 
+-------------------------------------------------------------------------+

1. Arrival of Action Potential: An action potential propagating along the presynaptic axon arrives at the bulbous axon terminal (synaptic knob).
2. Voltage-Gated $Ca^{2+}$ Influx: The wave of membrane depolarization sweeps across the terminal axolemma, triggering the rapid opening of voltage-gated calcium ($Ca^{2+}$) channels. Driven by an immense electrochemical gradient (extracellular free $Ca^{2+}$ concentration is roughly 10,000 times higher than intracellular free $Ca^{2+}$), calcium ions flood into the presynaptic terminal axoplasm.
3. Synaptic Vesicle Exocytosis: Intracellular $Ca^{2+}$ functions as an obligatory second messenger. Calcium binds to specialized vesicle-associated calcium-sensing proteins (such as synaptotagmin), which interact with SNARE protein complexes anchored to the plasma membrane. This interaction drives the membrane-bound synaptic vesicles to dock and fuse with the presynaptic terminal membrane, releasing thousands of neurotransmitter molecules into the synaptic cleft via exocytosis.
4. Diffusion Across the Cleft: Released neurotransmitter molecules diffuse rapidly across the microscopic, fluid-filled synaptic cleft, spanning the 20-50 nm gap in less than 0.2 milliseconds.
5. Postsynaptic Receptor Binding: Neurotransmitters bind reversibly and stereospecifically to complementary receptor proteins localized on the postsynaptic membrane (typically covering dendrites or the soma).
6. Postsynaptic Ion Channel Gating: Binding of the neurotransmitter induces a conformational change in the receptor that alters postsynaptic membrane permeability. Receptors operate through two mechanisms:
   • Ionotropic Receptors (Chemically/Ligand-Gated Ion Channels): The receptor macromolecule contains an integral ion channel pore. Binding directly opens or closes the pore, producing rapid, brief postsynaptic electrical responses.
   • Metabotropic Receptors (G-Protein Coupled Receptors): The receptor is physically separate from ion channels. Binding activates an intracellular G-protein and enzyme cascade (such as adenylate cyclase producing cyclic AMP), which indirectly opens ion channels or alters gene expression, eliciting slow, prolonged responses.
7. Termination of the Neurotransmitter Signal: To allow the postsynaptic cell to receive subsequent signals and avoid toxic continuous stimulation, the neurotransmitter must be cleared from the cleft within milliseconds.

---

Postsynaptic Potentials: EPSPs vs. IPSPs

Neurotransmitter binding to postsynaptic receptors does not produce an all-or-none action potential directly. Instead, it generates localized, graded alterations in membrane potential called postsynaptic potentials. Depending on the specific ion channels influenced by the receptor, these potentials are either excitatory or inhibitory:

+-------------------------------------------------------------------------+
|               EXCITATORY VS. INHIBITORY POSTSYNAPTIC POTENTIALS         |
|                                                                         |
|   EXCITATORY (EPSP):                        INHIBITORY (IPSP):          |
|   - Driven by Na+ influx                    - Driven by Cl- in or K+ out|
|   - Depolarizes toward threshold            - Hyperpolarizes away       |
|                                                                         |
|   mV                                        mV                          |
|   -55 |------- Threshold                    -55 |------- Threshold      |
|       |         /\                          -70 |------\                |
|   -70 |--------/  \ (EPSP)                      |       \______/ (IPSP) |
|   --------------------------------->        --------------------------->
+-------------------------------------------------------------------------+

1. Excitatory Postsynaptic Potentials (EPSPs)

An EPSP is a local, graded depolarization of the postsynaptic membrane that brings the membrane potential closer to the threshold required to fire an action potential.

• Ionic Mechanism: Excitatory neurotransmitters (such as glutamate or acetylcholine at nicotinic receptors) bind to chemically-gated cation channels permeable to both sodium ($Na^+$) and potassium ($K^+$). Because the electrochemical driving force pulling $Na^+$ inward is vastly stronger than the force pushing $K^+$ outward, $Na^+$ influx greatly exceeds $K^+$ efflux.
• Electrical Result: The net influx of positive charge depolarizes the local axolemma (for example, shifting membrane potential from -70 mV up to -65 mV). Although a single EPSP is subthreshold and cannot trigger an action potential on its own, it spreads passively toward the axon hillock, making the neuron more excitable.

2. Inhibitory Postsynaptic Potentials (IPSPs)

An IPSP is a local, graded hyperpolarization of the postsynaptic membrane that drives the membrane potential further away from the firing threshold, reducing the probability that the neuron will generate an action potential.

• Ionic Mechanism: Inhibitory neurotransmitters (such as GABA in the brain or glycine in the spinal cord) bind to chemically-gated channels that selectively open chloride ($Cl^-$) channels or potassium ($K^+$) channels.
  • Opening $Cl^-$ channels permits negatively charged chloride ions to diffuse down their concentration gradient into the axoplasm.
  • Opening $K^+$ channels allows positively charged potassium ions to diffuse down their concentration gradient out of the cell.
• Electrical Result: In either case, the internal face of the postsynaptic membrane becomes more negative relative to the outside (for example, dipping from -70 mV down to -75 mV or -80 mV). This hyperpolarization suppresses neuronal excitability, requiring a much larger subsequent excitatory input to achieve threshold.

---

Summation Dynamics at the Axon Hillock

A single multipolar neuron in the central nervous system may receive between 1,000 and 100,000 synaptic inputs across its dendritic tree and soma. Because an individual EPSP produces a modest depolarization of only 0.5 to 2.0 mV, isolated synaptic events cannot reach the -55 mV threshold. The postsynaptic neuron acts as an information integrator, continuously summing all excitatory and inhibitory inputs at its trigger zone (axon hillock), which maintains the lowest threshold due to an exceptionally high concentration of voltage-gated sodium channels.

+-------------------------------------------------------------------------+
|                        NEURAL SUMMATION MECHANICS                       |
|                                                                         |
|   TEMPORAL SUMMATION:                       SPATIAL SUMMATION:          |
|   One presynaptic neuron fires in           Multiple presynaptic neurons|
|   rapid succession at one synapse.          fire simultaneously at      |
|                                             different synapses.         |
|                                                                         |
|         Presynaptic                               Presynaptic 1         |
|            [ ]                                       [ ]                |
|             |  (Rapid pulses:                         \                 |
|             v   ||||||||)                              v                |
|         +-------+                                   +-------+           |
|         | Post- |                                   | Post- |<--- [ ]   |
|         | soma  |                                   | soma  | Presynaptic 2
|         +-------+                                   +-------+           |
|             |                                           |               |
|             v                                           v               |
|   Additive depolarization                     Additive depolarization   |
|   reaches threshold!                          reaches threshold!        |
+-------------------------------------------------------------------------+

1. Temporal Summation: Occurs when a single presynaptic terminal fires in rapid succession, releasing multiple waves of neurotransmitter before the initial postsynaptic potential has fully decayed. The successive graded EPSPs piggyback on one another, generating an additive depolarization that reaches threshold at the axon hillock.
2. Spatial Summation: Occurs when multiple distinct presynaptic terminals stimulate the postsynaptic neuron simultaneously at different anatomical locations on its dendrites and soma. The individual local currents converge and sum algebraically at the axon hillock.
3. Summation of EPSPs and IPSPs: When excitatory and inhibitory synapses fire concurrently, their electrical effects cancel each other out mathematically. If a neuron receives an EPSP of +5 mV and a simultaneous IPSP of -5 mV, the net membrane potential remains unchanged at -70 mV, preventing action potential discharge.

---

Mechanisms of Neurotransmitter Termination

To ensure precise millisecond-level neural signaling, neurotransmitters must be removed from the synaptic cleft immediately following receptor binding. The nervous system employs three dedicated clearance mechanisms:

1. Enzymatic Degradation: The neurotransmitter is chemically cleaved into inactive components by specific enzymes residing directly within the synaptic cleft or anchored to the postsynaptic membrane.
   • Acetylcholine (ACh) provides the classic model: Acetylcholinesterase (AChE), an extraordinarily efficient hydrolytic enzyme, cleaves ACh into acetate and choline. Choline is actively transported back into the presynaptic terminal via high-affinity choline transporters to synthesize fresh ACh.
   • Clinical Relevance: Organophosphate insecticides and chemical nerve agents (sarin, VX) irreversibly inhibit AChE. This causes massive, toxic accumulation of ACh at all cholinergic synapses, producing cholinergic crisis—characterized by severe salivation, lacrimation, urination, defecation, bronchoconstriction, violent muscle fasciculations, and fatal respiratory failure. In clinical medicine, reversible AChE inhibitors (e.g., pyridostigmine, donepezil) are used therapeutically to treat myasthenia gravis (by prolonging ACh at compromised skeletal motor endplates) and Alzheimer's disease (by augmenting central cholinergic transmission).
2. Cellular Reuptake: Intact neurotransmitter molecules are actively transported out of the synaptic cleft back into the presynaptic axon terminal or into neighboring astrocytes through specialized plasma membrane transport proteins.
   • Monoamine neurotransmitters—including serotonin, dopamine, and norepinephrine—are cleared primarily via sodium-dependent reuptake transporters (e.g., SERT, DAT, NET). Once returned to the cytoplasm, they are either repackaged into synaptic vesicles via vesicular monoamine transporters (VMAT) or degraded by intracellular enzymes, specifically monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT).
   • Clinical Relevance: Selective Serotonin Reuptake Inhibitors (SSRIs, such as fluoxetine and sertraline) selectively block SERT, elevating synaptic serotonin levels in cortical and limbic circuits to alleviate clinical depression and anxiety. Cocaine blocks dopamine reuptake transporters (DAT), causing prolonged dopamine accumulation in reward centers.
3. Passive Diffusion: Neurotransmitter molecules simply detach from receptors and diffuse laterally out of the synaptic cleft into surrounding interstitial fluid. Once in the interstitial space, they are diluted, absorbed by glial astrocytes, or swept into capillary circulation for hepatic degradation.

---

Major Neurotransmitters & Clinical Correlates

Neurotransmitters are classified biochemically into distinct molecular families, each exerting characteristic physiological actions within the central and peripheral nervous systems:

1. Acetylcholine (ACh)

Synthesized from choline and acetyl-coenzyme A (acetyl-CoA) by the enzyme choline acetyltransferase (ChAT). Acetylcholine serves as the primary neurotransmitter of:

• All somatic neuromuscular junctions innervating skeletal muscle.
• All preganglionic neurons of both the sympathetic and parasympathetic autonomic nervous systems.
• All postganglionic neurons of the parasympathetic division.
• Central cholinergic pathways arising from the basal forebrain (nucleus basalis of Meynert) projecting to the cerebral cortex and hippocampus, which are critical for attention, learning, and memory consolidation.
• Receptor Subtypes:
  • Nicotinic Receptors (nAChR): Ionotropic ligand-gated cation channels that allow rapid $Na^+$ influx, producing direct excitation. Located at the skeletal neuromuscular junction, autonomic ganglia, and adrenal medulla. Blocked by curare.
  • Muscarinic Receptors (mAChR): Metabotropic G-protein coupled receptors that elicit either excitation or inhibition depending on target tissue G-proteins (e.g., $M_2$ receptors in cardiac pacemaker cells open $K^+$ channels to slow heart rate; $M_3$ receptors in smooth muscle stimulate contraction and glandular secretion). Blocked by atropine.
• Clinical Relevance: Severe degeneration of cholinergic neurons within the nucleus basalis of Meynert is a hallmark neuropathological feature of Alzheimer's disease, leading to profound progressive dementia.

2. Biogenic Amines (Monoamines & Catecholamines)

Synthesized from aromatic amino acids, these molecules regulate emotional behavior, circadian biological clocks, and autonomic tone:

• Catecholamines (synthesized sequentially from the amino acid tyrosine: Tyrosine $\rightarrow$ L-DOPA $\rightarrow$ Dopamine $\rightarrow$ Norepinephrine $\rightarrow$ Epinephrine):
  • Dopamine: Concentrated within two major midbrain dopaminergic pathways: the nigrostriatal tract (arising from the substantia nigra and projecting to the basal nuclei, governing smooth voluntary motor coordination) and the mesolimbic/mesocortical tracts (arising from the ventral tegmental area, mediating reward, motivation, reinforcement, and addiction). Pathology: Progressive degeneration of dopaminergic neurons in the substantia nigra produces Parkinson's disease (resting tremor, rigidity, bradykinesia; treated with the dopamine precursor L-DOPA). Conversely, excessive dopaminergic activity in limbic pathways is implicated in schizophrenia (treated with dopamine $D_2$ receptor antagonists).
  • Norepinephrine (NE): Synthesized by postganglionic sympathetic neurons (innervating vascular smooth muscle, cardiac muscle, and adipose tissue) and brainstem neurons localized within the locus coeruleus of the pons. In the CNS, NE regulates arousal, vigilance, alertness, and mood. It binds to metabotropic alpha ($\alpha_1, \alpha_2$) and beta ($\beta_1, \beta_2, \beta_3$) adrenergic receptors.
  • Epinephrine (Adrenaline): Produced primarily by the chromaffin cells of the adrenal medulla (which secrete roughly 80% epinephrine and 20% norepinephrine) in response to sympathetic preganglionic stimulation. It circulates systemically as an endocrine hormone to amplify the sympathetic fight-or-flight response.
• Indoleamines:
  • Serotonin (5-Hydroxytryptamine / 5-HT): Synthesized from the essential dietary amino acid tryptophan. Although roughly 90% of bodily serotonin resides within enterochromaffin cells of the gastrointestinal tract (regulating gut motility), central serotonergic neurons originate in the brainstem raphe nuclei. Serotonin modulates mood, emotional stability, sleep-wake cycles, appetite, body temperature, and pain sensitivity. Depleted central serotonin levels are strongly linked to clinical depression and anxiety.
  • Histamine: Synthesized from histidine; released by hypothalamic neurons to promote wakefulness and cortical arousal (explaining why centrally-penetrating first-generation antihistamines induce sedation); also released by mast cells during allergic inflammatory reactions.

3. Amino Acid Neurotransmitters

• Glutamate: The primary and most abundant excitatory neurotransmitter of the central nervous system, accounting for over 50% of all central brain synapses. Glutamate binds to both ionotropic receptors (NMDA, AMPA, and kainate channels) and metabotropic receptors (mGluRs). Glutamate signaling through NMDA and AMPA receptors drives long-term potentiation (LTP), the molecular substrate for synaptic plasticity, learning, and memory consolidation. Pathology: Excitotoxicity—during acute ischemic stroke or traumatic brain injury, impaired cellular energy failure halts glutamate reuptake. Massive extracellular glutamate accumulation overstimulates NMDA receptors, causing catastrophic intracellular $Ca^{2+}$ overload that activates cytotoxic proteases and leads to widespread neuronal apoptosis.
• Gamma-Aminobutyric Acid (GABA): The primary inhibitory neurotransmitter of the brain. Synthesized from glutamate by the enzyme glutamic acid decarboxylase (GAD), which requires vitamin $B_6$ (pyridoxine) as a cofactor. Binding of GABA to $GABA_A$ receptors directly opens ligand-gated chloride ($Cl^-$) channels, triggering rapid $Cl^-$ influx and generating hyperpolarizing IPSPs that suppress neuronal firing. $GABA_A$ receptors contain allosteric regulatory binding sites for benzodiazepines (e.g., diazepam, lorazepam), barbiturates, and ethanol, all of which amplify GABAergic inhibition, producing sedation, muscle relaxation, and anticonvulsant effects.
• Glycine: The primary inhibitory neurotransmitter of the spinal cord and brainstem. Like GABA, glycine binds to ligand-gated chloride channels to produce hyperpolarizing IPSPs that control somatic motor neuron reflexes. Clinical pearl: The lethal poison strychnine acts as a competitive antagonist of glycine receptors in the spinal cord; by abolishing normal inhibitory post-synaptic tone, strychnine causes uncontrolled, agonizing motor neuron discharges, severe spastic muscle contractions, and asphyxiation.

4. Neuropeptides

Composed of short chains of amino acids (2 to 40 residues), neuropeptides act as neuromodulators, modifying synaptic strength over prolonged durations:

• Substance P: An 11-amino-acid peptide synthesized in primary unipolar sensory neurons of the dorsal root ganglia and released in the dorsal gray horns of the spinal cord. It serves as the primary chemical mediator transmitting noxious pain impulses to ascending spinothalamic tracts.
• Endorphins & Enkephalins: Endogenous opioid peptides (including beta-endorphin, dynorphins, and met-/leu-enkephalins) that bind to presynaptic and postsynaptic opioid receptors (mu, kappa, delta). They act as the body's natural analgesics, inhibiting the presynaptic release of substance P in the spinal cord and activating descending pain-suppressing pathways within the brainstem periaqueductal gray.

---

Comprehensive Neurotransmitter Reference Table